scholarly article | Q13442814 |
P50 | author | Håkan Ahlström | Q66190621 |
Joel Kullberg | Q91760902 | ||
Johanna Helmersson-Karlqvist | Q91965697 | ||
Viola Adamsson | Q114441307 | ||
Juan J Carrero | Q37828646 | ||
Peter Stenvinkel | Q37828656 | ||
Ulf Risérus | Q38626286 | ||
Karl Michaëlsson | Q44118143 | ||
Anders Larsson | Q59163549 | ||
Lars Lind | Q65992534 | ||
P2093 | author name string | Johan Arnlöv | |
Anna Witasp | |||
P2860 | cites work | Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study | Q28219755 |
Obesity | Q28275029 | ||
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells | Q34180480 | ||
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. | Q34184675 | ||
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism | Q34537657 | ||
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. | Q34713240 | ||
Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease | Q35664554 | ||
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk | Q37115260 | ||
Pentraxins, humoral innate immunity and tissue injury | Q37200012 | ||
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome | Q37309372 | ||
Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications | Q37944361 | ||
Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity | Q39477901 | ||
AdipoQ is a novel adipose-specific gene dysregulated in obesity | Q42813232 | ||
Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome | Q43181277 | ||
Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals | Q44072391 | ||
Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women | Q44291205 | ||
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. | Q44801998 | ||
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations | Q46071688 | ||
Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. | Q46525885 | ||
Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. | Q46530614 | ||
A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study | Q46686072 | ||
Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. | Q48770462 | ||
Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET) | Q51388639 | ||
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. | Q51469352 | ||
Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. | Q51571487 | ||
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. | Q51802963 | ||
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. | Q51906910 | ||
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. | Q53476226 | ||
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
P433 | issue | 5 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 1373-1379 | |
P577 | publication date | 2014-01-25 | |
P1433 | published in | Obesity | Q15763232 |
P1476 | title | Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss | |
P478 | volume | 22 |
Q88779694 | Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris |
Q35332533 | Associations between pentraxin 3 and severity of coronary artery disease |
Q92592401 | Bariatric surgery results in restoration of physiological plasma levels of pentraxine-3 |
Q40590809 | Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity |
Q34547583 | Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity? |
Q38380295 | Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial |
Q64960673 | Elevated Pentraxin 3 in Obese Adipose Tissue Promotes Adipogenic Differentiation by Activating Neuropeptide Y Signaling. |
Q33650222 | Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers |
Q91970155 | Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality |
Q89802634 | Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients |
Q51064056 | Plasma Pentraxin 3 as a biomarker of metabolic syndrome. |
Q39044356 | Plasma levels of pentraxin 3 in patients with spondyloarthritis |
Q59800409 | The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility |
Q37733630 | The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation |
Q35227705 | Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients |
Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
Search more.